Biodesign team receives funding to commercialize their innovation
The Biodesign Finland 2017 team has secured funding from Tekes and Aalto University for an 18-month project that aims at commercialization of their research-based innovation. The innovation that will make open heart surgery safer has been developed within the Biodesign Finland 2017 project together with heart surgeon Tommi Pätilä. Globally over one million open heart surgeries are performed annually and up to 20% of the patients acquire heart failure, which may lead to severe morbidities or be even fatal. The innovation aims at bringing down the numbers of the severe complications. The funding will be used for concept development, clinical testing, and commercialization research. The project is expected to result in a strong IPR position and a commercialization plan that may be, for example, a start-up company or a license agreement with an existing company. Tommi Pätilä together with the Biodesign Finland 2017 team (Sami Elamo, Kalle Kotilahti, and Jari Rantala) constitute the project team.
Biodesign Finland is an entrepreneurial program jointly organized by Aalto University, University of Helsinki, and the Hospital District of Helsinki and Uusimaa. For more information on Biodesign Finland, visit .
Read more news
Samu Taulu develops next-generation brain imaging methods
Associate Professor of neurostimulation and neuroimaging Samu Taulu develops more precise methods for understanding the brain
EAA Best Paper and Presentation Award for Young Researchers for postdoctoral researcher Thomas Deppisch
The awarded work shows how speech can be made clearer in noisy environments while still preserving directional cues
Professor Hanna Maylett: “Without time spent together, a shared vision cannot emerge”
According to Hanna Maylett, associate professor of film directing, a director doesn’t need to know all the answers; rather, their role is to create a process through which those answers can be discovered together.